145 related articles for article (PubMed ID: 31762944)
1. Correction: Metabolic pathway for the universal fluorescent recognition of tumor cells.
Fernandez-Carrascal A; Garcia-Algar M; Nazarenus M; Torres-Nuñez A; Guerrini L; Feliu N; Parak WJ; Garcia-Rico E; Alvarez-Puebla RA
Oncotarget; 2019 Nov; 10(61):6643. PubMed ID: 31762944
[TBL] [Abstract][Full Text] [Related]
2. Correction: Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells.
Tsai CH; Tsai HC; Huang HN; Hung CH; Hsu CJ; Fong YC; Hsu HC; Huang YL; Tang CH
Oncotarget; 2018 Oct; 9(85):35598. PubMed ID: 30473753
[TBL] [Abstract][Full Text] [Related]
3. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
[TBL] [Abstract][Full Text] [Related]
4. Correction: Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
Wang Z; Ma B; Li H; Xiao X; Zhou W; Liu F; Zhang B; Zhu M; Yang Q; Zeng Y; Sun Y; Sun S; Wang Y; Zhang Y; Weng H; Chen L; Ye M; An X; Liu J
Oncotarget; 2019 Oct; 10(58):6285. PubMed ID: 31692885
[TBL] [Abstract][Full Text] [Related]
5. Correction: Genipin suppresses colorectal cancer cells by inhibiting the Sonic Hedgehog pathway.
Kim BR; Jeong YA; Na YJ; Park SH; Jo MJ; Kim JL; Jeong S; Lee SY; Kim HJ; Oh SC; Lee DH
Oncotarget; 2018 Jun; 9(47):28796. PubMed ID: 29983897
[TBL] [Abstract][Full Text] [Related]
6. Correction: Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences.
Quagliariello V; Rossetti S; Cavaliere C; Di Palo R; Lamantia E; Castaldo L; Nocerino F; Ametrano G; Cappuccio F; Malzone G; Montanari M; Vanacore D; Romano FJ; Piscitelli R; Iovane G; Pepe MF; Berretta M; D'Aniello C; Perdonà S; Muto P; Botti G; Ciliberto G; Veneziani BM; De Falco F; Maiolino P; Caraglia M; Montella M; Iaffaioli RV; Facchini G
Oncotarget; 2017 Sep; 8(37):62816. PubMed ID: 28977991
[TBL] [Abstract][Full Text] [Related]
7. Correction: POPX2 is a novel LATS phosphatase that regulates the Hippo pathway.
Rahmat MB; Zhang S; Koh CG
Oncotarget; 2019 Oct; 10(56):5890-5891. PubMed ID: 31645909
[TBL] [Abstract][Full Text] [Related]
8. Correction: TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.
Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z
Oncotarget; 2019 Nov; 10(60):6540. PubMed ID: 31741718
[TBL] [Abstract][Full Text] [Related]
9. Correction: miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG
Oncotarget; 2018 Feb; 9(15):12534. PubMed ID: 29552331
[TBL] [Abstract][Full Text] [Related]
10. Correction: Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia.
Qiao A; Wang K; Yuan Y; Guan Y; Ren X; Li L; Chen X; Li F; Chen AF; Zhou J; Yang JM; Cheng Y
Oncotarget; 2018 Jun; 9(43):27318. PubMed ID: 29930768
[TBL] [Abstract][Full Text] [Related]
11. Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.
Yu X; Ai J; Cai L; Jing Y; Wang D; Dong J; Pascal LE; Zhang J; Luo R; Wang Z
Oncotarget; 2019 Dec; 10(67):7181-7182. PubMed ID: 31903175
[TBL] [Abstract][Full Text] [Related]
12. Correction: Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1.
Yin SY; Efferth T; Jian FY; Chen YH; Liu CI; Wang AHJ; Chen YR; Hsiao PW; Yang NS
Oncotarget; 2018 Aug; 9(63):32271. PubMed ID: 30181816
[TBL] [Abstract][Full Text] [Related]
13. Correction: Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting.
Kim JY; Han JH; Park G; Seo YW; Yun CW; Lee BC; Bae J; Moon AR; Kim TH
Oncotarget; 2018 Jun; 9(42):26977. PubMed ID: 29928495
[TBL] [Abstract][Full Text] [Related]
14. Correction: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.
Raneros AB; Minguela A; Rodriguez RM; Colado E; Bernal T; Anguita E; Mogorron AV; Gil AC; Vidal-Castiñeira JR; Márquez-Kisinousky L; Bulnes PD; Marin AM; García Garay MC; Suarez-Alvarez B; Lopez-Larrea C
Oncotarget; 2018 Aug; 9(67):32881. PubMed ID: 30214691
[TBL] [Abstract][Full Text] [Related]
15. Correction: CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway.
Hou T; Zhou L; Wang L; Kazobinka G; Zhang X; Chen Z
Oncotarget; 2019 Jan; 10(9):1010. PubMed ID: 30847028
[TBL] [Abstract][Full Text] [Related]
16. Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes.
Cedena MT; Rapado I; Santos-Lozano A; Ayala R; Onecha E; Abaigar M; Such E; Ramos F; Cervera J; Díez-Campelo M; Sanz G; Rivas JH; Lucía A; Martínez-López J
Oncotarget; 2018 Jul; 9(56):30936. PubMed ID: 30112119
[TBL] [Abstract][Full Text] [Related]
17. Correction: Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway.
Ouyang Z; Guo X; Chen X; Liu B; Zhang Q; Yin Z; Zhai Z; Qu X; Liu X; Peng D; Shen Y; Liu T; Zhang Q
Oncotarget; 2019 Oct; 10(58):6283-6284. PubMed ID: 31692899
[TBL] [Abstract][Full Text] [Related]
18. Correction: MiR-451 as a new tumor marker for gastric cancer.
Shen Y; Gong JM; Zhou LL; Sheng JH
Oncotarget; 2019 Oct; 10(59):6396. PubMed ID: 31695848
[TBL] [Abstract][Full Text] [Related]
19. Correction: Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway.
Chocry M; Leloup L; Kovacic H
Oncotarget; 2018 Jun; 9(42):26978-26979. PubMed ID: 29928496
[TBL] [Abstract][Full Text] [Related]
20. Correction: Se
Zhang HN; Feng WL; An CN; Li WG
Oncotarget; 2018 Nov; 9(92):36542. PubMed ID: 30559936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
